Person: TOKSOY ÖNER, EBRU
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
TOKSOY ÖNER
First Name
EBRU
Name
7 results
Search Results
Now showing 1 - 7 of 7
Publication Open Access Synthesis and characterization of interpenetrating network (IPN) based levan-polyacrylamide hydrogels and their application in conservation of cultural heritage(2023-11-01) ÜNAL YILDIRIM, SEMRA; OKTAR, FAİK NÜZHET; GENÇ, SEVAL; TOKSOY ÖNER, EBRU; Özen Sağlam R., Ünal Yıldırım S., Oktar F. N., Genç S., Erdem G., Toksoy Öner E.In this study, an IPN based enzymatic levan-polyacrylamide hydrogel (EL-PA) was developed and characterized for its structural, morphological, rheological properties and swelling kinetics to underline hydrogel properties and its potential use in paper conservation. The addition of levan also led to changes in the viscoelastic behavior of the hydrogels, with the complex viscosity of EL-PA samples showing pronounced dependence on shear rate. The swelling and the overall surface area of the hydrogels were increased with the addition of levan into the polymer network. Source associated structural differences were found to be negligible such that both microbially produced linear and enzymatically produced branched forms of levan performed equally well. Solvent loaded hydrogels were then applied on an artifact, a 19th century book of Namık Kemal, and investigated using FTIR, SEM, XRD and colorimetric analysis. Old adhesive layers were successfully removed, and hydrogels showed good compatibility and ease of application. This study has shown that levan has improved hydrogel properties and levan based systems bear high potential in conservation science.Publication Open Access Biosynthesis of Levan by Halomonas elongata 153B: Optimization for Enhanced Production and Potential Biological Activities for Pharmaceutical Field(2022-01-01) TOKSOY ÖNER, EBRU; Erdal Altıntaş Ö., TOKSOY ÖNER E., ÇABUK A., AYTAR ÇELİK P.Halophilic organisms are a novel attractive option as cell factories for the production of industrially valuable bioproducts. Halomonas elongata is the cell factory of choice for ectoine production, but its levan production has not been well researched. Based on this scientifc motivation, in this study, we evaluated the chemical and biological properties of levan produced by the halophilic extremophile Halomonas elongata 153B (HeL). First, the central composite design was used to determine the optimal process variables for maximum levan biosynthesis. Then, the levan produced from HeL was purifed, quantifed, and chemically characterized with FTIR, 1 H-NMR, and GPC analyses. This was followed by antioxidant, anti-infammatory, antibioflm, and antimicrobial activity tests to assess its biological activities as well as a cytotoxcity assay. Maximum levan yields of 5.13±0.38 g/L were achieved after dialysis at the optimum levels of process variables. The 1 H-NMR spectrum of HeL revealed characteristic signals. It showed a strong antioxidant activity of 67.88% and the best radical scavenger. At a concentration of 400 µg/mL, HeL showed the most anti-infammatory efcacy. Also, at all indicated concentrations (250, 500, 750, and 1000 μg/mL) HeL, acted against bioflms formed by Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 6538, Pseudomonas aeruginosa ATCC 11778, Candida albicans ATCC 10231. Furthermore, HeL displayed antimicrobial activities against all strains tested. Finally, HeL showed high Cell viability in all dosages and no cytotoxicity was observed. In light of these results, HeL may have high potential in the medical, pharmaceutical and dermo-cosmetics industries.Publication Open Access Co-production of levan with other high-value bioproducts: A review(2023-04-30) TOKSOY ÖNER, EBRU; de Siqueira E. C., TOKSOY ÖNER E.Levan is a homopolysaccharide of fructose that has both scientific and industrial importance, with various applications in health, pharmaceutical, cosmetic and food industries. Despite its broad spectrum of uses, there are only a limited number of commercial levan sources due to the high costs related to its production. To make production economically viable, efforts have been concentrated on the selection of levan-producing microorganisms, the genetic manipulation of new strains, and the use of inexpensive agro-industrial byproducts as substrates. Another efficient strategy involves the concomitant synthesis of other products with high market value and as such, the successful co-production of levan was demonstrated with fructooligosaccharides, ethanol, sorbitol, poly-ε-lysine, poly-γ-glutamic acid and polyhydroxyalkanoates. This paper offers a systematic review of important aspects regarding recent strategies involving the simultaneous synthesis of levan and other bioproducts of aggregate value reported to date and discusses the challenges and opportunities for its large-scale production and applications.Publication Open Access Production of a high molecular weight levan by Bacillus paralicheniformis, an industrially and agriculturally important isolate from the buffalo grass rhizosphere(2022-09-01) TOKSOY ÖNER, EBRU; Nasir A., Ahmad W., Sattar F., Ashfaq I., Lindemann S. R., Chen M., Van den Ende W., TOKSOY ÖNER E., Kirtel O., Khaliq S., et al.A new exopolysaccharide (EPS) producing Gram-positive bacterium was isolated from the rhizosphere of Bouteloua dactyloides (buffalo grass) and its EPS product was structurally characterized. The isolate, designated as LB1-1A, was identified as Bacillus paralicheniformis based on 16S rRNA gene sequence and phylogenetic tree analysis. The EPS produced by LB1-1A was identified as a levan, having beta(2 -> 6) linked backbone with beta(2 -> 1) linkages at the branch points (4.66%). The isolate LB1-1A yielded large amount (similar to 42 g/l) of levan having high weight average molecular weight (Mw) of 5.517 x10(7) Da. The relatively low degree of branching and high molecular weight of this levan makes B. paralicheniformis LB1-1A a promising candidate for industrial applications.Publication Open Access Production and characterization of a high molecular weight levan and fructooligosaccharides from a rhizospheric isolate of Bacillus aryabhattai(ELSEVIER, 2020-04) TOKSOY ÖNER, EBRU; Nasir, Anam; Sattar, Fazal; Ashfaq, Iram; Lindemann, Stephen R.; Chen, Ming-Hsu; Van den Ende, Wim; Oner, Ebru Toksoy; Kirtel, Onur; Khaliq, Shazia; Ghauri, M. Afzal; Anwar, Munir A.Bacillus aryabhattai GYC2-3 strain, capable of synthesizing EPS, was isolated from the rhizosphere of Taraxacum spp. plant. The EPS was identified as levan by C-13 NMR spectroscopy and methylation analysis. The levan produced had a high weight average molecular weight of 5.317 x 10(7) Da and degree of branching 5.19%. Thin layer chromatography and high-performance anion-exchange chromatography revealed that it is capable of producing broad range of fructooligosaccharides (FOS) and higher levels of FOS synthesis were observed with increasing sucrose concentrations. The optimum temperature, initial pH and sucrose concentration for levan biosynthesis were studied to be 30 degrees C, 8.0 and 250 g/L, respectively. Levan production was increased by similar to 38% (26 g/L) when provided aeration as compare to static cultures. To the best of our knowledge, this is the first report on biosynthesis of levan and FOS by a B. aryabhattai strain.Publication Metadata only Levan enhanced the NF-kappa B suppression activity of an oral nano PLGA-curcumin formulation in breast cancer treatment(ELSEVIER, 2021) TOKSOY ÖNER, EBRU; Eskandari, Zahra; Bahadori, Fatemeh; Yenigun, Vildan Betul; Demiray, Mutlu; Eroglu, Mehmet Sayip; Kocyigit, Abdurrahim; Oner, Ebru ToksoyChemoresistance (CR) is one of the reasons why chemotherapy agents like Gemcitabine (GMC) remain insufficient in healing breast cancer. Activation of Nuclear Factor-kappa B (NF-kappa B) during chemotherapy is known as an important factor in the development of CR. The hydrophobic polyphenol curcumin is shown to inhibit NF-kappa B and hence CR. The aim of this work was to increase the poor bioavailability of curcumin by loading it into the nano-micelles made of Poly (Lactide-co-Glycolide) (PLGA) and levan, where levan as a natural fructose homopolymer makes the nano-micelle more stable and increases its uptake using the fructose moieties. In this study, a PLGA-levan-curcumin formulation (PLC) was designed and characterized. The size was measured as 154.16 +/- 1.45 nm with a 67.68% encapsulation efficiency (EE%). The incorporation between the components was approved. Levan made the nano-micelles stable for at least three months, increased their uptake, and led to a 10,000-fold increase in the solubility of curcumin. The enhanced bioavailability of curcumin reduced the NF-kappa B levels elevated by GMC, both in vitro and in vivo. The PLC showed a complete tumor treatment, while GMC only showed a rate of 52%. These point to the great potential of the PLC to be used simultaneously with chemotherapy.Publication Open Access Understanding the effects of chitosan, chia mucilage, levan based composite coatings on the shelf life of sweet cherry(2023-08-01) TOKSOY ÖNER, EBRU; Mujtaba M., Ali Q., Yilmaz B. A., Seckin Kurubas M., Ustun H., ERKAN M., Kaya M., Cicek M., Oner E. T.Sweet cherry (Prunus avium L.) fruits are prone to quality and quantity loss in shelf-life conditions and cold storage due to their short post-harvest life. Until now efforts have been made to extend the shelf life of the sweet cherry. However, an efficient and commercially scalable process remains elusive. To contribute to this challenge, here in this study, biobased composite coatings consisting of chitosan, mucilage, and levan, were applied on sweet cherry fruits and tested for postharvest parameters in both market and cold storage conditions. Results demonstrated that the shelf life of sweet cherries can be extended until the 30th day while retaining important post-harvest properties like decreased weight loss, fungal deterioration, increased stem removal force, total flavonoid, L-ascorbic acid, and oxalic acid. Given the cost-effectiveness of the polymers used, the findings of this study indicate the feasibility of extending the shelf-life of sweet cherries on a larger scale.